
A cell-permeable, non-peptide inhibitor of MDM2-p53 interactions (Ki=120nM). Treatment of cancer cells activates p53 and accumulation of p21, p53, and MDM2. The structure mimics three p53 residues involved in binding to MDM2.
Shipping: Available products typically ship within 24/48h, via priority shipping.
Do you need support? Contact Customer Service or Technical Support.
Online Account
Access or Create Your Account
Regulatory Status |
RUO – Research Use Only |
---|